000 03481nam a22003257a 4500
001 CUHAS/MMED/6000186/T/15
003 CUHAS/MMED/6000186/T/15
005 20240418120832.0
008 210821b |||||||| |||| 00| 0 eng d
028 _bWurzburg Road 35, BMC Premises, Post Code: 33102:
028 _b P. O Box 1464, Mwanza – Tanzania:
028 _bPhone: +255 28 298 3384:
028 _bFax: +255 28 298 3386:
028 _bEmail: vc@bugando.ac.tz :
028 _bwww.bugando.ac.tz
035 _aCUHAS/MMED/6000186/T/15
040 _cddc
041 _aEnglish
100 _aElice Bendera
_922696
_d[Female]
_eCUHAS/MMED/6000186/T/15
245 _aRubella Seroprevalence and Associated Factors Among Infants With Features of the Congenital Rubella Syndrome Attending at Bugando Medical Centre, Mwanza Tanzania
260 _aMwanza, Tanzania:
_bCatholic University of Health and Allied Sciences [CUHAS - Bugando] :
_c2018
300 _a xiv; 48 Pages
300 _aIncludes References and Appendices
520 _aAbstract: Background: Congenital Rubella Syndrome (CRS) affect millions of children globally and is one of the cause of infant mortality and lifelong disability due to severe birth defects. It remains a public health problem in a significant number of resource limited countries. Global health experts encourage use of rubella vaccination, with the primary aim of preventing CRS. This study aimed to determine prevalence of probable CRS cases, rubella antibodies and associated factors among infants suspected to have CRS. Methods: This was a cross sectional hospital based study which included 174 infants aged ≤ 12 months with clinical features of CRS. The study was conducted between September 2017 and March 2018 at Bugando Medical Centre. Social demographic and other relevant information were gathered using structured using structured questionnaire. Screening for clinical signs and symptoms suggestive of CRS were performed. Blood samples were collected and sera were used to test for specific Rubella IgM and IgG antibodies using indirect enzymes-linked immunosorbent assay (ELISA). Results: The median age of enrolled children was 5.5[1 – 24] weeks; of these 83 (47.7%) were neonates. The majority 114(65.5%) of these infants were infants were from urban areas and only 13.2% had received MR vaccine. Out of 174 infants investigated, 111 (63.8%, 95%CI: 56.6-70.9) were IgG Rubella seropositive whereas none was IgM Rubella seropositive. Twenty six (14.9%) had probable CRS. On univariate analysis being neonates (OR 2.3; 95% CI: 1.2 – 4.3; p=0.012) was significantly associated with Rubella IgG seropositivity, whereas history of abortion had borderline significance (OR 2.5; 95%CI 0.9 – 6.5; p=0.063. By multivariate logistic regression analysis only being neonate independently predicted rubella IgG seropositivity (OR 2.3; 95% CI 1.2 – 4.4; p=0.012). Conclusion: A Significant proportion children (<12 months) with suspected CRS are IgG seropositive which is predicted by being a neonate (0.4 weeks); this indicates high maternal seroprevalence. In addition, a significant proportion of infants with suspected CRS can be grouped as probable CRS which are more likely to be Rubella IgG seropositive.
600 _xPaediatrics and Child Health
_933433
700 _aAdolfine Hokororo
_922795
700 _aMariam M. Mirambo
_922927
700 _aTumaini Mhada
_922832
942 _2ddc
_cMP
999 _c18417
_d18417